New strategy for COVID-19 vaccination: targeting the receptor-binding domain of the SARS-CoV-2 spike protein

Vaccines, Free Full-Text

How studies of coronavirus immunity can inform better vaccines, treatments

Modern Paradigm Towards Potential Target Identification for Antiviral (SARS-nCoV-2) and Anticancer Lipopeptides: A Pharmacophore-Based Approach - AJMB: Volume 14, Issue 1, Year 2022 - AJMB

Junzhi Wang's research works National Institutes for Food and Drug Control, China, Beijing (NIFDC) and other places

Medicina, Free Full-Text

Understanding SARS-CoV-2 antibody binding

Lipid nanoparticles boost potential vaccine against SARS-CoV-2 - Advanced Science News

Will Peptides Help to Stop COVID-19?

PDF) Modern Paradigm Towards Potential Target Identification for Antiviral (SARS-nCoV-2) and Anticancer Lipopeptides: A Pharmacophore-Based Approach

Applications of genetic engineering in COVID-19

Full article: Role of antibody-dependent enhancement (ADE) in the virulence of SARS-CoV-2 and its mitigation strategies for the development of vaccines and immunotherapies to counter COVID-19

Browse Articles Cellular & Molecular Immunology

Frontiers Overview of Immune Response During SARS-CoV-2 Infection: Lessons From the Past